Specific Inhibition of the Transcription Factor Ci by a Cobalt(III) Schiff Base鈥揇NA Conjugate
详细信息 查看全文
- 作者：Ryan R. Hurtado ; Allison S. Harney ; Marie C. Heffern ; Robert J. Holbrook ; Robert A. Holmgren ; Thomas J. Meade
- 刊名：Molecular Pharmaceutics
- 出版年：2012
- 出版时间：February 6, 2012
- 年：2012
- 卷：9
- 期：2
- 页码：325-333
- 全文大小：476K
- 年卷期：v.9,no.2(February 6, 2012)
- ISSN：1543-8392
文摘
We describe the use of Co(III) Schiff base鈥揇NA conjugates, a versatile class of research tools that target C2H2 transcription factors, to inhibit the Hedgehog (Hh) pathway. In developing mammalian embryos, Hh signaling is critical for the formation and development of many tissues and organs. Inappropriate activation of the Hedgehog (Hh) pathway has been implicated in a variety of cancers including medulloblastomas and basal cell carcinomas. It is well-known that Hh regulates the activity of the Gli family of C2H2 zinc finger transcription factors in mammals. In Drosophila the function of the Gli proteins is performed by a single transcription factor with an identical DNA binding consensus sequence, Cubitus Interruptus (Ci). We have demonstrated previously that conjugation of a specific 17 base-pair oligonucleotide to a Co(III) Schiff base complex results in a targeted inhibitor of the Snail family C2H2 zinc finger transcription factors. Modification of the oligonucleotide sequence in the Co(III) Schiff base鈥揇NA conjugate to that of Ci鈥檚 consensus sequence (Co(III)-Ci) generates an equally selective inhibitor of Ci. Co(III)-Ci irreversibly binds the Ci zinc finger domain and prevents it from binding DNA in vitro. In a Ci responsive tissue culture reporter gene assay, Co(III)-Ci reduces the transcriptional activity of Ci in a concentration dependent manner. In addition, injection of wild-type Drosophila embryos with Co(III)-Ci phenocopies a Ci loss of function phenotype, demonstrating effectiveness in vivo. This study provides evidence that Co(III) Schiff base鈥揇NA conjugates are a versatile class of specific and potent tools for studying zinc finger domain proteins and have potential applications as customizable anticancer therapeutics.